Standout Papers
- Histone deacetylase inhibitors: molecular mechanisms of action (2007)
- Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells (2000)
- Erythroleukemic Differentiation (1978)
- Histone deacetylase inhibitors: Potential in cancer therapy (2009)
- Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. (2000)
- Discovery and development of SAHA as an anticancer agent (2007)
Immediate Impact
21 by Nobel laureates 36 from Science/Nature 67 standout
Citing Papers
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
Works of P A Marks being referenced
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors
2005
Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| P A Marks | 7116 | 659 | 635 | 1841 | 714 | 66 | 8.7k | |
| Henrik Daub | 5353 | 364 | 458 | 1683 | 483 | 56 | 7.5k | |
| Román Herrera | 6655 | 469 | 267 | 1824 | 323 | 42 | 8.5k | |
| Aviv Gazit | 5250 | 498 | 919 | 3232 | 1042 | 99 | 9.6k | |
| Chris J. Vlahos | 5756 | 938 | 326 | 926 | 490 | 68 | 8.5k | |
| Christian Rommel | 7186 | 782 | 1300 | 1701 | 577 | 87 | 10.0k | |
| Lawrence R. Dick | 5904 | 248 | 258 | 2132 | 603 | 49 | 8.0k | |
| Lowell H. Ericsson | 4912 | 471 | 472 | 755 | 1259 | 77 | 7.6k | |
| Roberto D. Polakiewicz | 6603 | 696 | 598 | 1423 | 750 | 69 | 9.0k | |
| Sarah J. Parsons | 6238 | 305 | 404 | 2978 | 387 | 115 | 9.6k | |
| Paolo Salomoni | 4745 | 366 | 476 | 1418 | 1117 | 104 | 6.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...